Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
FlexShopper (FPAY) PT Raised to $3.50 at Maxim Group
-
DelMar Pharmaceuticals to Host Key Opinion Leader Summit on Glioblastoma Multiforme and the Potential for Treatment with VAL-083
-
PAVmed Secures Financing up to $14 Million for Advancement of its Lead Products to Commercialization
-
PAVmed Secures Financing up to $14 Million for Advancement of its Lead Products to Commercialization
-
BeiGene, Ltd. (BGNE) PT Raised to $210 at Maxim Group
-
Aegion (AEGN) PT Raised to $23 at Maxim Group
-
Maxim Group Starts Mistras Group (MG) at Buy
-
Guardion Health Sciences Closes $8.4 Million Underwritten Public Offering
-
Guardion Health Sciences Closes $8.4 Million Underwritten Public Offering
-
AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING
-
AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING
-
Maxim Group Downgrades Texas Roadhouse (TXRH) to Hold
-
Guardion Health Sciences (GHSI) Prices 24.5M Share Common Offering at $0.342/Sh
-
Guardion Health Sciences Announces Pricing of $8.4 Million Underwritten Public Offering
-
Guardion Health Sciences Announces Pricing of $8.4 Million Underwritten Public Offering
-
AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
-
AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
-
Maxim Group Downgrades Gilead Sciences (GILD) to Hold
-
AmpliTech Engages Maxim Group to Assist With Its Growth Strategy and Up-list to Nasdaq
-
AmpliTech Engages Maxim Group to Assist With Its Growth Strategy and Up-list to Nasdaq
-
Maxim Group Upgrades Titan Pharmaceuticals (TTNP) to Buy
-
PlacementTracker Publishes Q3 2019 PIPE and Private Placement Markets League Tables
-
BioNano Genomics, Inc. (BNGO) Prices 20.94M Shares at $0.86/Share with Warrants
-
Bionano Genomics Announces Pricing of $18 Million Underwritten Public Offering
-
Signature Bank (SBNY) PT Lowered to $175 at Maxim Group
-
Dolphin Entertainment, Inc. (DLPN) Prices 2.7M Share at $0.7828/Sh
-
Dolphin Entertainment, Inc. Announces Pricing of $2.1 Million Offering of Common Stock
-
Dolphin Entertainment, Inc. (DLPN) Announces Proposed Common Share Offering
-
Dolphin Entertainment, Inc. Announces Proposed Public Offering of Common Stock
-
Nicolet Bankshares (NCBS) PT Raised to $75 at Maxim Group
-
Titan Pharma (TTNP) Prices 40M Unit Offering at $0.0225/Unit
-
Titan Pharmaceuticals Announces Pricing Of $9.0 Million Underwritten Public Offering
-
Maxim Group Downgrades Titan Medical (TMDI) to Hold
-
Maxim Group Starts FlexShopper (FPAY) at Buy
-
Maxim Group Starts BioCardiAa (BCDA) at Buy
-
Maxim Group Upgrades AIM ImmunoTech (AIM) to Buy
-
LiveXLive Media (LIVX) PT Lowered to $5 at Maxim Group
-
Maxim Group Downgrades Bio-Key International (BKYI) to Hold
-
Maxim Group Starts Nephros (NEPH) at Buy
-
Priority Income Fund, Inc. Prices Offering of Preferred Stock
-
Priority Income Fund, Inc. Prices Offering of Preferred Stock
-
Priority Income Fund, Inc. Launches Preferred Stock Offering
-
Priority Income Fund, Inc. Launches Preferred Stock Offering
-
NanoViricides, Inc. Files Form S-1 Registration Statement
-
AzurRx Biopharma (AZRX) PT Lowered to $3 at Maxim Group
-
PennantPark Investment Corporation Prices Public Offering of $75 Million 5.50% Unsecured Notes Due 2024
-
Aeterna Zentaris Announces Closing of Approximately $5.0 Million Registered Direct Offering
-
Aeterna Zentaris Announces Closing of Approximately $5.0 Million Registered Direct Offering
-
PennantPark Investment Corporation Announces Public Offering of Unsecured Notes Due 2024
-
AppTech Corp. Announces Launch of Up to $10 Million Offering

